Octocog alfa (recombinant human coagulation factor VIII)

BIOLOGICAL2 trials

Sponsors

Baxalta now part of Shire

Conditions

Hemophilia A

Phase 4

China ADVATE PTP Study

CompletedNCT02170402

Baxalta now part of ShireHemophilia A

Start: 2014-06-26End: 2016-05-31Updated: 2021-05-03

Unknown Phase

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

CompletedNCT02634723

Baxalta now part of ShireHemophilia A

Start: 2015-12-23End: 2016-06-30Updated: 2021-03-17

Related Papers

Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A

Clinical and Applied Thrombosis/Hemostasis2021-01-015 citations